Research Education Component
研究教育部分
基本信息
- 批准号:10474608
- 负责人:
- 金额:$ 29.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaBasic ScienceClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesCompetenceDementiaDevelopmentDiagnosisDirect CostsDiseaseEducational ActivitiesEducational process of instructingEquilibriumExtramural ActivitiesFacultyFamilyFosteringFundingFuture GenerationsGoalsGrantGrowthHealth Care CostsHealth ServicesHuman ResourcesIncidenceInfrastructureInstitutionInternationalKnowledgeLaboratory ResearchLeadMentorsMentorshipNatureNerve DegenerationParticipantPatientsPopulationPostdoctoral FellowResearchResearch PersonnelResearch Project GrantsResearch Project SummariesResearch SupportResearch TrainingResource SharingResourcesScienceScientistServicesSocietiesSpecialistTalentsTrainingTraining ProgramsTraining SupportTraining and InfrastructureTranslatingTranslational ResearchWorkaging populationcareercareer developmentclinical careclinical centercollaborative environmentcostdesigneducation researcheducation resourcesexperiencefaculty mentorfaculty researchhealthy aginginnovationinterdisciplinary collaborationneurobehavioralnovelprogramsresearch and developmentservice interventionsuccesstranslational research program
项目摘要
PROJECT SUMMARY
The Research Education Component (REC) is aimed at fulfilling two critical needs in the Alzheimer's disease
(AD) and Alzheimer's disease related dementias (ADRD) community: 1) the number of current researchers and
clinical specialists in AD/ADRD are clearly inadequate to meet the needs of the rapid increase in the AD
population in the US and around world and 2) while we have made advances in bridging the knowledge gaps
in understanding neurodegenerative mechanisms through many years of research, advances in clinical care
are still lacking. As such, new scientists trained in the breadth of approaches with deep clinical
appreciation are required to promote progress in translational research in the AD/ADRD field and to
develop innovative and effective strategies for the diagnosis and the treatment. The REC program has
been specifically designed for selected Program Participants to provide rigorous scientific research training in
the AD/ADRD field along with extensive clinical exposure.
The REC specifically aims to train talented and promising junior faculty and research associates and
supports their career growth with individualized Research Plan and Mentoring Plan with clearly articulated
goals. The REC emphasizes rigorous scientific training in fundamental aspects of neurodegeneration and
mechanisms of diseases involving AD/ADRD and clinical perspectives through classroom teaching, AD/ADRD-
related laboratory research and mentored neurodegenerative clinical experiences combined with educational
forums that address important topics in clinical and translational AD/ADRD research and career growth.
The REC has identified a group of diverse promising candidates who will be encouraged to develop
new competencies under the mentorship of a faculty Mentoring committee composed of outstanding
Program Faculty including both clinical and basic researchers. The REC will also utilize the vast
educational and training resources available through CADRC-associated institutions including formal
programs, training grants, and other educational resources to enable the identified participants to advance
their research careers. This REC program will not only provide the necessary infrastructure for the training
of new AD/ADRD-related clinical/basic researchers, but also stimulate interdepartmental/interdisciplinary
collaborations among CADRC clinical and basic science researchers to serve the overall goal to accelerate
collaborative health services, interventional science, and translational neurobehavioral science research
specifically in AD/ADRD, augmenting activities of both the CADRC and national and international efforts.
项目概要
研究教育部分 (REC) 旨在满足阿尔茨海默氏病的两个关键需求
(AD) 和阿尔茨海默病相关痴呆 (ADRD) 群体:1) 目前研究人员的数量和
AD/ADRD的临床专家显然不足以满足AD快速增长的需求
美国和世界各地的人口以及 2) 我们在弥合知识差距方面取得了进展
通过多年的研究和临床护理的进步了解神经退行性机制
仍然缺乏。因此,新科学家接受了深入临床方法的广度培训
需要赞赏来促进 AD/ADRD 领域转化研究的进展,并
制定创新且有效的诊断和治疗策略。 REC 计划有
专门为选定的计划参与者提供严格的科学研究培训
AD/ADRD 领域以及广泛的临床接触。
REC 的具体目标是培养有才华、有前途的初级教师和研究助理,
通过个性化的研究计划和指导计划来支持他们的职业发展,并明确阐述
目标。 REC 强调神经退行性变和神经退行性疾病基本方面的严格科学培训
AD/ADRD 相关疾病的机制以及通过课堂教学的临床观点、AD/ADRD-
相关实验室研究和指导的神经退行性临床经验与教育相结合
讨论临床和转化 AD/ADRD 研究和职业发展重要主题的论坛。
REC 已经确定了一组多元化的有前途的候选人,他们将被鼓励发展
在由杰出人士组成的教师指导委员会的指导下培养新的能力
项目教师包括临床和基础研究人员。 REC 还将利用大量
通过 CADRC 相关机构提供的教育和培训资源,包括正规机构
计划、培训补助金和其他教育资源,使确定的参与者能够进步
他们的研究生涯。该 REC 计划不仅为培训提供必要的基础设施
新的 AD/ADRD 相关临床/基础研究人员,同时也刺激了跨部门/跨学科的研究
CADRC临床和基础科学研究人员之间的合作,服务于加速总体目标
协作医疗服务、介入科学和转化神经行为科学研究
特别是在 AD/ADRD 方面,加强 CADRC 的活动以及国家和国际努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiongwei Zhu其他文献
Xiongwei Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiongwei Zhu', 18)}}的其他基金
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
Mettl3 依赖性 RNA m6A 失调在阿尔茨海默病中的作用
- 批准号:
10739065 - 财政年份:2023
- 资助金额:
$ 29.93万 - 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
- 批准号:
9261605 - 财政年份:2013
- 资助金额:
$ 29.93万 - 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
- 批准号:
8829930 - 财政年份:2013
- 资助金额:
$ 29.93万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
叶黄素调控脂代谢紊乱所致年龄相关性黄斑病变的血-视网膜屏障损伤机制研究
- 批准号:82373570
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 29.93万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 29.93万 - 项目类别:
Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care
为不同人群进行基于血液的阿尔茨海默病生物标志物测试做好准备:开发初级保健决策支持工具
- 批准号:
10722716 - 财政年份:2023
- 资助金额:
$ 29.93万 - 项目类别: